Sunday, November 8, 2026

EUR/CHF Bearish By 1% In The Last 21 Sessions

ViaNews Editorial Team

December 7, 2023

EUR/CHF Bearish By 1% In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.87% for the last 21 sessions. At 18:06 EST on Thursday, 7 December, EUR/CHF (EURCHF) is $0.94.

EUR/CHF's yearly highs and lows, it's 0.521% up from its 52-week low and 6.418% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Eur/usd forex signal: euro meltdown has more room to run - 06 December 2023. According to DailyForex on Wednesday, 6 December, "The EUR/USD pair will react to several important economic data from Europe and the US. ", "Forex Brokers We Recommend in Your Region See full brokers list 1 Read full review Get Started BrokerGeoLists.push({type:'ReviewsNonPartner',id:'horizontal-top-5',size:5,fullReviewText:`Read full review`,getStartedText:`Get Started`,readReviewText:`Review`});Bearish viewSell the EUR/USD pair and set a take-profit at 1.0730."
  • Eur/usd slips past 1.0800 on Tuesday amidst broad-market US dollar bid. According to FXStreet on Tuesday, 5 December, "The Euro's backslide sees the EUR/USD slipping through the 200-day Simple Moving Average (SMA) currently treading water near 1.0820.", "Continued bearish pressure will see a technical barrier from the 50-day SMA which has turned bullish and is rising into the 1.0700 handle, while bidders will be looking to stage a recovery back over the 200-day SMA before the EUR/USD slides too deep into retracement territory between 1.0750 and 1.0700."
  • According to FXStreet on Tuesday, 5 December, "If the EUR/USD continues to fall, it may come into contact with the 100-day SMA at 1.0774 as a first point of support. ", "If the EUR/USD continues to fall, it may encounter the initial point of support at the December low of 1.0804 (December 4,5). "
  • Eur/usd forex signal: bears prevail as it flips key support level - 05 December 2023. According to DailyForex on Tuesday, 5 December, "The EUR/USD price retreated and lost the important resistance point at 1.0823, the lowest swing on November 17th. ", "Forex Brokers We Recommend in Your Region See full brokers list 1 Read full review Get Started BrokerGeoLists.push({type:'ReviewsNonPartner',id:'horizontal-top-5',size:5,fullReviewText:`Read full review`,getStartedText:`Get Started`,readReviewText:`Review`});Bearish viewSell the EUR/USD pair and set a take-profit at 1.0735."
  • Eur/usd extends the decline below 1.0800, eurozone retail sales eyed. According to FXStreet on Wednesday, 6 December, "The EUR/USD pair remains under selling pressure below the 1.0800 psychological mark during the early Asian session on Wednesday. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com